Raynaud disease
Information
- Disease name
- Raynaud disease
- Disease ID
- DOID:10300
- Description
- "A peripheral vascular disease that is characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or cyanosis in response to cold exposure or stress." [url:https\://medlineplus.gov/raynaudsdisease.html, url:https\://www.hopkinsmedicine.org/health/conditions-and-diseases/raynauds-phenomenon]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02506062 | Completed | N/A | A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) | July 2015 | August 2018 |
| NCT00251238 | Completed | Phase 2 | Efficacy and Tolerability of Ginkgo Biloba Extract in Patients With Raynaud´s Phenomenon | November 2005 | April 2006 |
| NCT00253331 | Completed | Phase 2/Phase 3 | Lab Study of MQX-503 in Treatment of Raynaud's | November 2004 | September 2005 |
| NCT00626665 | Completed | Phase 3 | Randomised Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma | December 2007 | April 2008 |
| NCT03699436 | Completed | N/A | Effectiveness of Electric Stimulation Therapy in Raynaud's Phenomenon | October 1, 2018 | February 20, 2019 |
| NCT01743612 | Completed | N/A | Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis. | January 2012 | June 2015 |
| NCT01926847 | Completed | Phase 2 | Digital Flow Enhancement in Raynaud's Phenomenon With an sGC (Soluble Guanylate Cyclase) Stimulator | October 2013 | June 2014 |
| NCT03094910 | Completed | N/A | Investigation of the Rewarming og the Fingers After Cooling and the Autonomic Nervous System in Raynaud's Phenomenon | January 1, 2017 | February 28, 2019 |
| NCT00004786 | Completed | Phase 3 | Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Iloprost for Raynaud's Phenomenon Secondary to Systemic Sclerosis | December 1995 | |
| NCT03027674 | Completed | Early Phase 1 | Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud | August 2016 | August 2016 |
| NCT02298777 | Recruiting | Metabolomic Analysis of Systemic Sclerosis | December 2014 | February 2026 | |
| NCT02642146 | Terminated | Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study | January 2015 | June 2019 | |
| NCT02374320 | Terminated | Phase 2/Phase 3 | Exparel as a Nerve Block for Severe Hand Pain | November 2014 | March 2016 |
| NCT03869008 | Terminated | N/A | Potential Benefit for Non Invasive Vagus Nerve Stimulation Using GammaCore in the Treatment of Raynaud's Phenomena. | April 30, 2019 | October 16, 2020 |
| NCT02183779 | Unknown status | N/A | PORH and Response to Cold in Raynaud's Phenomenon. | June 2014 | June 2017 |
| NCT00934427 | Unknown status | Phase 3 | Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms | June 2009 | July 2010 |
| NCT04898036 | Withdrawn | N/A | Phototherapy For Treatment Of Raynaud's Phenomenon | August 2022 | March 2023 |
- Disase is a (Disease Ontology)
- DOID:341
- Cross Reference ID (Disease Ontology)
- ICD10CM:I73.0
- Cross Reference ID (Disease Ontology)
- MESH:D011928
- Cross Reference ID (Disease Ontology)
- MIM:179600
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:195295006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0034734
- Exact Synonym (Disease Ontology)
- Raynaud's disease
- Exact Synonym (Disease Ontology)
- Raynaud's syndrome
- MedGen concept unique identifier (MedGen Concept name)
- C0034734
- MedGen unique identifier (MedGen Concept name)
- 20473
- MeSH unique ID (MeSH (Medical Subject Headings))
- D011928